{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T22:23:00Z","timestamp":1768256580263,"version":"3.49.0"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T00:00:00Z","timestamp":1541635200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0207242","type":"journal-article","created":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T18:43:36Z","timestamp":1541702616000},"page":"e0207242","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["The prognosis of heart failure patients: Does sodium level play a significant role?"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9367-7592","authenticated-orcid":true,"given":"Tamrat Befekadu","family":"Abebe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyob Alemayehu","family":"Gebreyohannes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9205-9442","authenticated-orcid":true,"given":"Yonas Getaye","family":"Tefera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshaya Srikanth","family":"Bhagavathula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Asfaw","family":"Erku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sewunet Admasu","family":"Belachew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Begashaw Melaku","family":"Gebresillassie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadesse Melaku","family":"Abegaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,11,8]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2010.165","article-title":"Epidemiology and risk profile of heart failure","volume":"8","author":"AL Bui","year":"2011","journal-title":"Nature Reviews Cardiology"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.amjmed.2013.07.021","article-title":"Prevalence of hyponatremia and association with mortality: results from NHANES","volume":"126","author":"S Mohan","year":"2013","journal-title":"The American journal of medicine"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/17482940701210179","article-title":"Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial","volume":"9","author":"J Rossi","year":"2007","journal-title":"Acute cardiac care"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/eurheartj\/ehl542","article-title":"Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry","volume":"28","author":"M Gheorghiade","year":"2007","journal-title":"European heart journal"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.amjcard.2005.03.002","article-title":"Hyponatremia in congestive heart failure","volume":"95","author":"RM Oren","year":"2005","journal-title":"The American journal of cardiology"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1527-5299.2005.04180.x","article-title":"Hyponatremia and heart failure\u2014pathophysiology and implications","volume":"11","author":"DA Sica","year":"2005","journal-title":"Congestive Heart Failure"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10741-010-9193-3","article-title":"Significance of hyponatremia in heart failure","volume":"17","author":"L Bettari","year":"2012","journal-title":"Heart failure reviews"},{"issue":"19","key":"ref8","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1001\/jama.290.19.2581","article-title":"Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model","volume":"290","author":"DS Lee","year":"2003","journal-title":"Jama"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/eurjhf\/hfs099","article-title":"Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta-analysis(dagger): Meta-Analysis Global Group in Chronic heart failure (MAGGIC)","volume":"14","author":"D Rusinaru","year":"2012","journal-title":"European journal of heart failure"},{"issue":"19","key":"ref10","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/01.CIR.0000165065.82609.3D","article-title":"Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study","volume":"111","author":"L Klein","year":"2005","journal-title":"Circulation"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","article-title":"Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials","volume":"297","author":"M Gheorghiade","year":"2007","journal-title":"Jama"},{"issue":"24","key":"ref12","first-page":"1798","article-title":"Improvement of hyponatraemia during hospitalisation for acute heart failure is not associated with improvement of prognosis: an analysis from the Korean Heart Failure (KorHF) registry","volume":"98","author":"SE Lee","year":"2012","journal-title":"Heart (British Cardiac Society)"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/CIRCHEARTFAILURE.111.961011","article-title":"Impact of change in serum sodium concentration on mortality in patients hospitalized with heart failure and hyponatremia","volume":"4","author":"VD Madan","year":"2011","journal-title":"Circulation Heart failure"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.cardfail.2013.04.003","article-title":"Hyponatremia in Heart Failure: Time for a Trial","volume":"19","author":"SR Goldsmith","journal-title":"Journal of cardiac failure"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12963-017-0145-1","article-title":"National mortality burden due to communicable, non-communicable, and other diseases in Ethiopia, 1990\u20132015: findings from the Global Burden of Disease Study 2015","volume":"15","author":"A Misganaw","year":"2017","journal-title":"Population Health Metrics"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12872-016-0418-9","article-title":"Patients with HFpEF and HFrEF have different clinical characteristics but similar prognosis: a retrospective cohort study","volume":"16","author":"TB Abebe","year":"2016","journal-title":"BMC cardiovascular disorders"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12872-017-0680-5","article-title":"Anemia in severe heart failure patients: does it predict prognosis?","volume":"17","author":"TB Abebe","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.gheart.2012.12.006","article-title":"The epidemiology of congestive heart failure: the Framingham Heart Study perspective","volume":"8","author":"SS Mahmood","year":"2013","journal-title":"Global heart"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2265.2006.02583.x","article-title":"Characteristics and mortality of severe hyponatraemia\u2014a hospital-based study","volume":"65","author":"G Gill","year":"2006","journal-title":"Clinical endocrinology"},{"issue":"8","key":"ref20","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1445-5994.2010.02217.x","article-title":"Severe hyponatraemia in elderly hospitalized patients: prevalence, aetiology and outcome","volume":"40","author":"DS Shapiro","year":"2010","journal-title":"Internal medicine journal"},{"key":"ref21","article-title":"Iron deficiency anaemia: assessment, prevention and control: a guide for programme managers","year":"2001"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jjcc.2013.07.012","article-title":"Hyponatremia is an independent predictor of adverse clinical outcomes in hospitalized patients due to worsening heart failure","volume":"63","author":"S Hamaguchi","year":"2014","journal-title":"Journal of cardiology"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cardfail.2011.09.005","article-title":"Hyponatremia and long-term outcomes in chronic heart failure\u2014an observational study from the Duke Databank for Cardiovascular Diseases","volume":"18","author":"L Bettari","year":"2012","journal-title":"Journal of cardiac failure"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/eurjhf\/hfr086","article-title":"Prevalence and prognostic significance of hyponatraemia in outpatients with chronic heart failure","volume":"13","author":"L Balling","year":"2011","journal-title":"European journal of heart failure"},{"issue":"9","key":"ref25","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/eurheartj\/ehp032","article-title":"The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failure","volume":"30","author":"R Vazquez","year":"2009","journal-title":"European heart journal"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"e002668","DOI":"10.1161\/JAHA.115.002668","article-title":"Hyponatremia and Worsening Sodium Levels Are Associated With Long-Term Outcome in Patients Hospitalized for Acute Heart Failure","volume":"5","author":"DY Lu","year":"2016","journal-title":"Journal of the American Heart Association"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"506","DOI":"10.5603\/CJ.2013.0136","article-title":"Hyponatremia as predictor of worse outcome in real world patients admitted with acute heart failure","volume":"20","author":"JC Arevalo Lorido","year":"2013","journal-title":"Cardiology journal"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ijcard.2017.12.048","article-title":"Heart failure in sub-Saharan Africa: A contemporaneous systematic review and meta-analysis","volume":"257","author":"VN Agbor","year":"2018","journal-title":"International journal of cardiology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/VHRM.S131259","article-title":"The changing trend of cardiovascular disease and its clinical characteristics in Ethiopia: hospital-based observational study","volume":"13","author":"YG Tefera","year":"2017","journal-title":"Vascular health and risk management"},{"issue":"21","key":"ref30","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1136\/heartjnl-2016-310894","article-title":"Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study","volume":"103","author":"P Andell","year":"2017","journal-title":"Heart"},{"issue":"12","key":"ref31","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial","volume":"297","author":"MA Konstam","year":"2007","journal-title":"Jama"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1527-5299.2005.04180.x","article-title":"Hyponatremia and heart failure\u2014pathophysiology and implications","volume":"11","author":"DA Sica","year":"2005","journal-title":"Congestive heart failure (Greenwich, Conn)"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1210\/jcem-59-5-924","article-title":"Hyponatremia in congestive heart failure: implications for neurohumoral activation and responses to orthostasis","volume":"59","author":"LS Lilly","year":"1984","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"5","key":"ref34","first-page":"Iv80","article-title":"Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure","volume":"75","author":"M Packer","year":"1987","journal-title":"Circulation"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5694\/j.1326-5377.2003.tb05445.x","article-title":"Digoxin in heart failure and cardiac arrhythmias","volume":"179","author":"TJ Campbell","year":"2003","journal-title":"The Medical journal of Australia"},{"issue":"8","key":"ref36","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","year":"1997","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"ref37","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1097\/01.ASN.0000135121.81744.75","article-title":"Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial","volume":"15","author":"MG Shlipak","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"key":"ref38","article-title":"Anemia at Hospital Admission and Its Relation to Outcomes in Patients With Heart Failure (from the Polish Cohort of 2 European Society of Cardiology Heart Failure Registries)","author":"A Tyminska","year":"2017","journal-title":"The American journal of cardiology"},{"issue":"1","key":"ref39","first-page":"45","article-title":"[Differences in clinical profile and outcome in patients with decompensated heart failure and systolic dysfunction or preserved systolic function]","volume":"57","author":"SM Macin","year":"2004","journal-title":"Revista espanola de cardiologia"},{"issue":"11","key":"ref40","first-page":"1050","article-title":"[Clinical characteristics and medium-term prognosis of patients with heart failure and preserved systolic function. Do they differ in systolic dysfunction?]","volume":"56","author":"S Ojeda","year":"2003","journal-title":"Revista espanola de cardiologia"},{"issue":"10","key":"ref41","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/hrt.2003.021733","article-title":"Predicting sudden death in patients with mild to moderate chronic heart failure","volume":"90","author":"MT Kearney","year":"2004","journal-title":"Heart (British Cardiac Society)"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"TE Owan","year":"2006","journal-title":"The New England journal of medicine"},{"issue":"10","key":"ref43","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"B Pitt","year":"1999","journal-title":"The New England journal of medicine"},{"issue":"21","key":"ref44","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM200005253422107","article-title":"Hyponatremia","volume":"342","author":"HJ Adrogu\u00e9","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"ref45","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3810\/pgm.2000.5.1.1068","article-title":"Hyponatremia and hypernatremia: a systematic approach to causes and their correction","volume":"107","author":"PJ Fall","year":"2000","journal-title":"Postgraduate medicine"},{"issue":"10","key":"ref46","first-page":"2387","article-title":"Management of hyponatremia","volume":"69","author":"KP Goh","year":"2004","journal-title":"American family physician"},{"issue":"5","key":"ref47","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cardfail.2009.12.021","article-title":"The critical link of hypervolemia and hyponatremia in heart failure and the potential role of arginine vasopressin antagonists","volume":"16","author":"JK Ghali","year":"2010","journal-title":"Journal of cardiac failure"},{"issue":"4","key":"ref48","doi-asserted-by":"crossref","first-page":"473","DOI":"10.5301\/jn.5000060","article-title":"Hyponatremia: a problem-solving approach to clinical cases","volume":"25","author":"F. Assadi","year":"2012","journal-title":"Journal of nephrology"},{"issue":"10","key":"ref49","first-page":"1","article-title":"Sodium disorders in the emergency department: a review of hyponatremia and hypernatremia","volume":"14","author":"CL Pfennig","year":"2012","journal-title":"Emergency medicine practice"},{"issue":"6","key":"ref50","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00005792-199311000-00001","article-title":"Pontine and extrapontine myelinolysis: a neurologic disorder following rapid correction of hyponatremia","volume":"72","author":"BI Karp","year":"1993","journal-title":"Medicine"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cardfail.2012.11.007","article-title":"A randomized controlled pilot study of outcomes of strict allowance of fluid therapy in hyponatremic heart failure (SALT-HF)","volume":"19","author":"NM Albert","year":"2013","journal-title":"Journal of cardiac failure"},{"issue":"9","key":"ref52","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4330\/wjc.v5.i9.317","article-title":"Hyponatremia in patients with heart failure","volume":"5","author":"TD Filippatos","year":"2013","journal-title":"World journal of cardiology"},{"issue":"6","key":"ref53","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/0003-4819-100-6-777","article-title":"Renal response to captopril in severe heart failure: role of furosemide in natriuresis and reversal of hyponatremia","volume":"100","author":"VJ Dzau","year":"1984","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"ref54","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1159\/000176926","article-title":"Successful treatment of hyponatremia with angiotensin-converting enzyme inhibitors in patients with congestive heart failure","volume":"86","author":"M Elisaf","year":"1995","journal-title":"Cardiology"},{"issue":"3","key":"ref55","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1388-9842(00)00094-5","article-title":"Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure","volume":"2","author":"S Paterna","year":"2000","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"ref56","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1067\/mhj.2003.166","article-title":"Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects","volume":"145","author":"G Licata","year":"2003","journal-title":"Am Heart J"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-1-4615-4871-3_34","article-title":"Molecular pharmacology of human vasopressin receptors","volume":"449","author":"M Thibonnier","year":"1998","journal-title":"Advances in experimental medicine and biology"},{"issue":"3","key":"ref58","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1053\/snep.2001.21647","article-title":"Physiology and pathophysiology of renal aquaporins","volume":"21","author":"TH Kwon","year":"2001","journal-title":"Seminars in nephrology"},{"issue":"1","key":"ref59","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrneph.2012.246","article-title":"Hyponatraemia: more than just a marker of disease severity?","volume":"9","author":"RW Schrier","year":"2013","journal-title":"Nature reviews Nephrology"},{"issue":"16","key":"ref60","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1001\/jama.291.16.1963","article-title":"Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial","volume":"291","author":"M Gheorghiade","year":"2004","journal-title":"Jama"},{"issue":"12","key":"ref61","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial","volume":"297","author":"MA Konstam","year":"2007","journal-title":"Jama"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0223007","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T00:00:00Z","timestamp":1568851200000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0207242","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T16:49:09Z","timestamp":1662396549000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0207242"}},"subtitle":[],"editor":[{"given":"Yoshiaki","family":"Taniyama","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,11,8]]},"references-count":61,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0207242","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0223007","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,8]]}}}